Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Regulatory
Pamelor — AVENTYL HYDROCHLORIDE
Application NDA014684 (NDA)
Pamelor — PAMELOR
Application NDA018013 (NDA)
Pamelor — AVENTYL
Application NDA014685 (NDA)
Pamelor — PAMELOR
Application NDA018012 (NDA)
Anafranil — ANAFRANIL
Application NDA019906 (NDA)
Restoril — RESTORIL
Application NDA018163 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)